2. Academic Validation
  3. Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells

Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells

  • Nat Chem Biol. 2016 Dec;12(12):1023-1030. doi: 10.1038/nchembio.2194.
Cecilia Lopez-Sambrooks 1,  Shiteshu Shrimal 2,  Carol Khodier 3,  Daniel P Flaherty 4,  Natalie Rinis 1,  Jonathan C Charest 1,  Ningguo Gao 5,  Peng Zhao 6,  Lance Wells 6,  Timothy A Lewis 3,  Mark A Lehrman 5,  Reid Gilmore 2,  Jennifer E Golden 4,  Joseph N Contessa 1 7
Affiliations

Affiliations

  • 1 Department of Therapeutic Radiology, Yale School of Medicine, New Haven, Connecticut, USA.
  • 2 Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
  • 3 Center for the Science of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
  • 4 University of Kansas Specialized Chemistry Center, University of Kansas, Lawrence, Kansas, USA.
  • 5 Department of Pharmacology, UT Southwestern Medical Center at Dallas, Dallas, Texas, USA.
  • 6 Complex Carbohydrate Research Center, Department of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA.
  • 7 Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut, USA.
PMID: 27694802 DOI: 10.1038/nchembio.2194
Abstract

Asparagine (N)-linked glycosylation is a protein modification critical for glycoprotein folding, stability, and cellular localization. To identify small molecules that inhibit new targets in this biosynthetic pathway, we initiated a cell-based high-throughput screen and lead-compound-optimization campaign that delivered a cell-permeable inhibitor, NGI-1. NGI-1 targets oligosaccharyltransferase (OST), a hetero-oligomeric Enzyme that exists in multiple isoforms and transfers oligosaccharides to recipient proteins. In non-small-cell lung Cancer cells, NGI-1 blocks cell-surface localization and signaling of the epidermal growth factor receptor (EGFR) glycoprotein, but selectively arrests proliferation in only those cell lines that are dependent on EGFR (or Fibroblast Growth Factor, FGFR) for survival. In these cell lines, OST inhibition causes cell-cycle arrest accompanied by induction of p21, autofluorescence, and cell morphology changes, all hallmarks of senescence. These results identify OST inhibition as a potential therapeutic approach for treating receptor-tyrosine-kinase-dependent tumors and provides a chemical probe for reversibly regulating N-linked glycosylation in mammalian cells.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-117383
    99.95%, Virus Protease抑制剂
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z